About: Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published in The Lancet

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1999 (uk) im Dezember 1999 veröffentlichter wissenschaftlicher Artikel (de) article publié dans la revue scientifique The Lancet (fr) scientific article published in The Lancet (en) ശാസ്ത്രപ്രബന്ധം (ml)
publication date	wds:Q56928579-E755F95E-1464-4986-B46E-1C2D42A46D2C
publication date	1999-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56928579-A9C7AA95-282A-47AB-A776-3B3AEFFA2149
language of work or name	English
cites work	wds:Q56928579-097B0676-41D3-4012-AB4E-436FEF318256 wds:Q56928579-14AB35CE-0D0D-4AF8-B82C-5BCE04BB4DB0 wds:Q56928579-24A97B5A-FDE1-48EB-BE1E-920E65B2F0D6 wds:Q56928579-2865A4EA-99E6-47E8-A936-D0C6580DBE8E wds:Q56928579-3C7A5BB0-9D25-4FCE-9C79-CF181619BA7E wds:Q56928579-4329A1B8-9EAD-4C55-8AE6-BC68DD9FC24F wds:Q56928579-46491324-4157-424A-961E-DB0A2883D9BE wds:Q56928579-4F0CFEC5-FF15-4E96-B086-F9876B519555 wds:Q56928579-5C6E082F-C467-41DA-BC97-4BEE30EA28F2 wds:Q56928579-6160A8AD-A1A2-48B8-ADFC-B9228420FB72 wds:Q56928579-68AF8076-F2CF-47B8-AB38-43DF793BA625 wds:Q56928579-6A4EBA70-301D-46AC-82E3-BEBEE80CE456 wds:Q56928579-6DA9893A-018D-493B-BE50-DE0CD27640E1 wds:Q56928579-72D23C75-DB00-47DD-8E49-F0A662402C1A wds:Q56928579-73FDCCF2-D780-406D-8E7E-73A4D607E7EE wds:Q56928579-787EB474-7B61-4ECC-BBB5-3DA58641AB6F wds:Q56928579-8472DB31-8A3E-46A9-B33C-63DF48E0B22F wds:Q56928579-94AF4532-FF82-4C3A-A628-C500C6F7AF91 wds:Q56928579-9F02F374-105E-430B-A00D-A7F19348B29A wds:Q56928579-A454E943-F20F-4DAA-B9E6-1C3DA6B88EF5 wds:Q56928579-BC3937EA-2061-4675-BEDD-70C1249D042E wds:Q56928579-BE9C9F22-66F9-4FFA-BCB4-8A23DD556102 wds:Q56928579-C9F2D9F9-28A9-42C3-B3B8-C9ACB3FC73F7 wds:Q56928579-DAF5309A-FEE7-463D-804C-DE6F8E42717F wds:Q56928579-F8A3289C-739F-49BA-8EE6-5C563B3B018F wds:Q56928579-FA12BB7D-92A4-4E52-99AD-8D8467EF642C wds:Q56928579-FC6FF72C-B9EF-416E-ABCB-8F801F2ADBCA
cites work	A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Subacute stent thrombosis: evolving issues and current concepts Pathology of Acute and Chronic Coronary Stenting in Humans A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Coronary-Artery Stents — Gauging, Gorging, and Gouging Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group Periprocedural creatine kinase-MB elevations: long-term impact and clinical implications Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study Minimal myocardial damage during coronary intervention is associated with impaired outcome
author name string	wds:Q56928579-1F4C560F-0BBC-440F-A060-02F1DE8F6A6F wds:Q56928579-460BD07C-965B-41C7-A7DF-ED3129907DDB wds:Q56928579-4C6CD554-FB01-440A-AA97-47A26ED5D963 wds:Q56928579-4F5D8FE7-84AF-4E78-B60E-4CF01EF6C75E wds:Q56928579-8BF54383-1208-44FB-8ACA-93D4DCBA9ADD wds:Q56928579-B2552F3A-145B-4F1E-8846-C2330EBF0601 wds:Q56928579-E4273DD2-F60E-4971-9693-A00F17CFC951 wds:Q56928579-F6AED4FB-E8A5-4D13-A55C-0EEF4B4B3A24
author name string	J Burton E Cohen K M Anderson C F Cabot J Booth D Talley N Kleiman S Sapp
rdfs:label	Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (en) Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (nl)
skos:prefLabel	Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (en) Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (nl)
name	Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (en) Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial (nl)
author	wds:Q56928579-0A32EEB7-21E6-429C-ACC9-1364D38B4FE7 wds:Q56928579-17EBA508-1600-48D8-892E-A572A8CDD69E wds:Q56928579-6A40E960-5E0D-4AF2-8948-DDF5F177D7CE wds:Q56928579-7FC389AF-4686-4A8C-BB52-C87BABA8DCEB
author	Robert Califf Eric J. Topol A Michael Lincoff Daniel B. Mark
title	wds:Q56928579-CE243D9F-78F1-497B-B061-CB45FCD00C9D
title	Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (en)
page(s)	wds:Q56928579-D236055A-31DC-4668-BD76-65ED4E58DED8
page(s)	2019-2024

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software